Patient Rating:

4.7 out of 5

56 Patient Ratings
25 Patient Comments

Mary Elizabeth Hartnett, M.D.

Specialties

Languages

  • English

Clinical Details

Locations

Schedule An Appointment Clinical Office Address
(801) 581-2352 John A. Moran Eye Center
65 N Mario Capecchi
Salt Lake City, UT 84132
Map

Bio

M.E. Hartnett is a vitreoretinal surgeon, who treats and manages adult and pediatric retinal cases. Dr. Hartnett's clinical interests include vitreoretinal surgical diseases, including retinopathy of prematurity, or abnormal blood vessel development in the eye of a premature baby; pediatric vitreoretinopathies; trauma; retinal detachments; and diabetic eye disease. She also has a special interest in age-related macular degeneration.

Dr. Hartnett joined the Moran Eye Center in 2010 and will be building a pediatric retina center and a pediatric and adult retina clinical practice here. She performs surgery at both the Moran Eye Center and the Moran Pediatric Clinic at Primary Children's Medical Center.

Board Certification and Academic Information

Academic Departments Ophthalmology/Visual Sciences - Professor
Neurobiology and Anatomy - Adjunct Professor
Pediatrics - Adjunct Professor
Academic Divisions Pediatric Administration
Board Certification American Board of Ophthalmology

Patient Ratings

The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending doctor
4.9
My confidence in doctor
4.9
Time doctor spent with me
4.7
Doctor spoke using clear language
4.8
Doctor's effort to include me in decisions
4.7
Doctor's concern for questions & worries
4.7
Doctor's explanation of condition/problem
4.6
Wait time at clinic
3.7
Doctor's friendliness and courtesy
4.8

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

March 30, 2014

Could have been better if physician and fellow examined at same time so I wouldn't have to have discomfort of lights twice.

March 17, 2014

Doctor Hartnet is very professional and caring with patients--she includes me in decisions--I credit her with saving my sight in my right eye---she is an excellent physican----

February 12, 2014

The care that I receive from Dr Hartnett is very good and she explains things well. However the assistant that dilated my eyes when they should not have been was not good at all.

December 22, 2013

Dr. Hartnet was always very caring, engaged and helpful. A couple of her assistants/fellows (?) were less so and maybe even a little rough during exam of retinal tear (however, that may have been absolutely necessary. Dr. Hartnet was more gentle in her approach).

November 28, 2013

I am usually seen by Dr. Hobbs and then by Dr. Hartnett. Both are very professional, and have done a wonderful job with my complicated case.

November 18, 2013

We would recommend Dr. Hartnett but the wait time was excessive. Also we were sent out to the reception waiting room and then called back into an exam room to schedule a procedure. We had to wait again for the person scheduling the procedure. It just seemed like the flow of how things ran there needed some work.

November 18, 2013

Excellent.

November 11, 2013

Dr. B was awesome. He was straight forward explaining the situation to me abt what was happening and might happen with my retina. Too bad he couldn't/didn't need to stay longer and visit. I like him.

October 21, 2013

I never saw the physician, just her fellow.

October 14, 2013

I am always thankful for specialists. They have worked hard for their knowledge.

October 07, 2013

Dr. Hartnett has been fantastic. She has done everything possible to deal with my difficult case with the best possible outcome.

October 07, 2013

Dr. Hartnett is clearly a consummate professional who is willing to explain and discuss my condition and the possible need for further treatment.

September 09, 2013

We drive 4 hours in order to see Dr. Lenahan, she is incredible to work with. I wouldn't want to see another provider even if they were "in-network"!

September 09, 2013

I have a problem with hearing when I can't see. Another thing I have a problem with is that by the time they actual DR comes in I am so dilated that I can't see the Dr.'s face. I don't know what she looks like.

September 02, 2013

okay. Primary Doctors time with us was limited

August 08, 2013

Good

July 15, 2013

I think there is a disconnect between me and the care provider. The care provider seems to be focusing her attention on my good eye where I really am still concerned with my bad eye. I could really use some help in knowing what I can do to minimize the symptoms or resolve the problem. I feel lost. I cannot describe the difficulties i've had in trying to cope with this and yet I feel like i'm left on my own to try and figure it out.

June 05, 2013

I was unable to see the doctor - my contact lenses were out. But he was terrific. Very competent and patient.

June 04, 2013

thanks to dr harnet my son can see!!!!!!!!!!!!!!

April 01, 2013

everything was excellent except for the LONG wait.

February 26, 2013

I am extremely impressed with the way doctor hartnett, and shokor(spelled wrong) diagnosed my problem. I've never been shown that kind and that much attention to any of my problems ever. Dr. Hartnett even came back after emergency surgery to make sure I was seen and looked at. I really felt like they cared and they wanted to make sure I was diagnosed correctly. My problem I know is a difficult one to diagnose, but I know they will find out what the problem is and help me. I would highly recommend others to go to the Moran eye center.

February 18, 2013

Dr. Hartnet and the other doctor were very nice and thorough

November 12, 2012

dr hartnet is the best pediatric retna specialist. she has a great bedside manner

November 06, 2012

I have a serious retinal condition and these guys/gals knew what they were doing/talking about. Excellent facility.

November 05, 2012

Dr. Hartnett pays such close attention my description of symptoms, and my physical exam is so meticulous. Her analysis of the situation is transparent which I appreciate.

Academic Profile

Board Certification and Academic Information

Academic Departments Ophthalmology/Visual Sciences - Professor
Neurobiology and Anatomy - Adjunct Professor
Pediatrics - Adjunct Professor
Academic Divisions Pediatric Administration
Board Certification American Board of Ophthalmology

Academic Office Locations

Academic Office Phone Number Academic Office Address
John A. Moran Eye Center
Moran Eye Center
65 N Mario Capecchi
Salt Lake City, UT 84132

Academic Bio

Mary Elizabeth Hartnett is a Doctor of Ophthalmology with a practice at the John A. Moran Eye Center at the University of Utah. She is a Professor at the University of Utah Department of Ophthalmology and Visual Sciences and an Adjunct Professor at the University of Utah Departments of Neurobiology and Anatomy and Department of Pediatrics. Dr. Hartnett is a vitreoretinal surgeon, who treats and manages adult and pediatric retinal cases. Dr. Hartnett's clinical interests include vitreoretinal surgical diseases, including retinopathy of prematurity, or abnormal blood vessel development in the eye of a premature baby; pediatric vitreoretinopathies; trauma; retinal detachments; and diabetic eye disease. She also has a special interest in age-related macular degeneration.

She received her undergraduate degree at Rensselaer Polytechnic Institute in Biology in the combined BS/MD program. She received her medical degree from Albany Medical College in the combined BS/MD program. Dr. Hartnett fulfilled post graduate training at Children’s Hospital and Schepens Eye Research Institute, Harvard University in molecular and cell biology and interned at University Hospitals of Cleveland. She completed a residency at University Hospitals of Cleveland, VA Medical Center in ophthalmology. She was awarded fellowships at Schepens Retina Associates and Massachusetts Eye and Ear Infirmary, Harvard Medical School, Schepens Retina Associates in vitreoretinal medical/surgical training in adult retina. Dr. Hartnett also worked as a research fellow at Schepens Eye Research Institute, Harvard Medical School and at Harvard University as Senior research ophthalmology fellow. Other training includes St. Peter's Hospital in hospice team training.

Dr. Hartnett joined the Moran Eye Center in 2010 and will be building a pediatric retina center and a pediatric and adult retina clinical practice here. She performs surgery at both the Moran Eye Center and the Moran Pediatric Clinic at Primary Children's Medical Center.

Education

Education History

Type School Degree
Post Graduate Training Children’s Hospital and Schepens Eye Research Institute, Harvard University
Molecular and Cell Biology
Postgraduate Studies
Fellowship Schepens Retina Associates, Massachusetts Eye and Ear Infirmary, Harvard Medical School
Vitreoretinal Medical/Surgical Training in Pediatric Retina
Fellow
Research Fellow Harvard University
Senior Research Ophthalmology Fellow
Research Fellow
Fellowship Schepens Retina Associates
Chief Fellow
Fellowship Massachusetts Eye and Ear Infirmary, Harvard Medical School, Schepens Retina Associates
Vitreoretinal Medical/Surgical Training in Adult Retina
Fellow
Research Fellow Schepens Eye Research Institute, Harvard Medical School
Research Fellow
Residency University Hospitals of Cleveland, VA Medical Center
Ophthalmology
Resident
Internship University Hospitals of Cleveland
Intern
Professional Medical Albany Medical College
Medicine (Combined BS/MD program)
M.D.
Undergraduate Rensselaer Polytechnic Institute
Biology (Combined BS/MD program)
B.S.
Other Training St. Peter's Hospital
Hospice Team Training

Publications

Selected Provider Publications

Journal Article

  1. Sleath B, Blalock SJ, Robin A, Hartnett ME, Covert D, DeVellis B, Giangiacomo (2010)Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations.  Eye (London, England), 24(4),624-31
  2. Zayed M, Uppal A, Hartnett M(2010)New-Onset Maternal Gestational Hypertension and Risk of Retinopathy of Prematurity.  Investigative Ophthalmology & Visual Science,
  3. Budd SJ, Hartnett M(2010)Increased Angiogenic Compounds during Persistent Avascular Retina in a Model of ROP  Archives of Ophthalmology, 128(8),1014-21
  4. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M and the SCORE Study Investigator Grou(2009)SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.  Ophthalmology, 116(3),504-12
  5. Ulmasov B, Bruno J, Gordon N, Hartnett ME, Edwards J(2009)Chloride intracellular channel protein-4 functions in angiogenesis by supporting acidification of vacuoles along the intracellular tubulogenic pathway.  American Journal of Pathology, 174(3),1084-96
  6. Brucker AJ, Qin H, Antoszyk AN, Beck RW, Bressler NM, Browning DJ, Elman MJ, Glassman AR, Gross JG, Kollman C, Wells JA 3r(2009)Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings.  Archives of Ophthalmology, 127(2),132-40
  7. Byfield G, Budd S, Hartnett M(2009)The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.  Investigative Ophthalmology & Visual Science, 50(7),3360-5
  8. Diabetic Retinopathy Clinical Research Network (DRCR.net), Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman (2009)Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.  Archives of Ophthalmology, 127(3),245-51
  9. Scott IU, Blodi BA, Ip MS, Vanveldhuisen PC, Oden NL, Chan CK, Gonzalez V and the SCORE Study Investigator Grou(2009)SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type.  Ophthalmology, 116(4),756-61
  10. Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Green MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati (2009)CCR3 is a target for age-related macular degeneration diagnosis and therapy.  Nature, 460(7252),225-30
  11. Budd S, Byfield G, Martiniuk D, Geisen P, Hartnett M(2009)Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.  Experimental Eye Research, 89(5),718-27
  12. Hartnett ME, Tinkham N, Paynter L, Geisen P, Rosenberg P, Koch G, Cohen K(2009)Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus.  American Journal of Ophthalmology, 148(6),895-901.e1
  13. Reynolds R, Hartnett ME, Rosner B, Atkinson J, Giclas PC, Seddon J(2009)Plasma Complement Components and Activation Fragments are Associated with Age-Related Macular Degeneration Genotypes and Phenotypes  Investigative Ophthalmology & Visual Science,
  14. Scott IU, Bressler NM, Bressler SB, Browning DJ, Chan CK, Danis RP, Davis MD, Kollman C, Qin H and the and the Diabetic Retinopathy Clinical Research Network Study Grou(2008)Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema.  Retina, 28(1),36-40
  15. Vinekar A, Trese MT, Capone A Jr on behalf of PhotoROP grou(2008)Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach.  American Journal of Ophthalmology, 145(3),548-555
  16. Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Danis RP, Elman MJ, Friedman SM, Glassman AR, Gross JG, Li HK, Murtha TJ, Stone TW, Sun JK on behalf of the Diabetic Retinopathy Clinical Research Networ(2008)Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.  American Journal of Ophthalmology, 145(5),894-901
  17. Davis MD, Bressler SB, Aiello LP, Bressler NM, Browning DJ, Flaxel CJ, Fong DS, Foster WJ, Glassman AR, Hartnett ME, Kollman C, Li HK, Qin H, Scott I(2008)Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema.  Investigative Ophthalmology & Visual Science, 49(5),1745-52
  18. Hartnett ME, Board RJ, Houghton (2008)Subretinal hemorrhage after lens-sparing vitrectomy in infants born at or under 24 weeks gestation.  Retina, 28(3 Suppl),S69-74
  19. Geisen P, Peterson LJ, Martiniuk D, Uppal A, Saito Y, Hartnett M(2008)Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.  Molecular Vision, 14345-57
  20. Hartnett ME, Martiniuk D, Byfield G, Geisen P, Zeng G, Bautch V(2008)Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease.  Investigative Ophthalmology & Visual Science, 49(7),3107-14
  21. Saito Y, Uppal A, Byfield G, Budd S, Hartnett M(2008)Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.  Investigative Ophthalmology & Visual Science, 49(4),1591-8
  22. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett M(2008)Vascular endothelial growth factor in eye disease.  Progress in Retinal and Eye Research, 27(4),331-71
  23. Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H for DRCR.ne(2008)Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.  Ophthalmology, 115(8),1366-71, 1371.e1
  24. Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, Qin H for Health Research and the Diabetic Retinopathy Clinical Research Networ(2008)A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.  Retina, 28(7),919-30
  25. Diabetic Retinopathy Clinical Research Networ(2008)A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema  Ophthalmology, 1151445-1456
  26. Jacobson MA, Tan QX, Girling V, Poon C, Van Natta M, Jabs DA, Inokuma M, Maecker HT, Bredt B, and Sinclair E, for the Studies of Ocular Complications of AIDS Research Grou(2008)Poor predictive value of cytomegalovirus (CMV)-Specific T cell assays for the development of CMV retinitis in patients with AIDS  Clinical Infectious Diseases, 46458-466
  27. Writing Committee for The Photographic Screening for Retinopathy of Prematurity Study (Photo- ROP(2008)Primary Outcomes Ophthalmology  Retina, 28S47-S54
  28. Zeng G, Taylor SM, McColm JR, Kappas NC, Kearney JB, Williams LH, Hartnett ME, Bautch V(2007)Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. [This was a plenary paper with a commentary]  Blood, 109(4),1345-52
  29. Peterson LJ, Wittchen ES, Geisen P, Burridge K, Hartnett M(2007)Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1.  Experimental Eye Research, 84(4),737-44
  30. Saito Y, Geisen P, Uppal A, Hartnett M(2007)Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.  Molecular Vision, 13840-53
  31. Bhavsar AR, Ip MS, Glassman AR, DRCRnet and the SCORE Study Group(2007)The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials.  American Journal of Ophthalmology, 144(3),454-6
  32. Zayed MA, Yuan W, Leisner TM, Chalothorn D, McFadden AW, Schaller MD, Hartnett ME, Faber JE, Parise L(2007)CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angiogenesis.  Circulation Research, 101(11),1185-93
  33. Steering Committee of Diabetic Retinopathy Clinical Research Networ(2007)A phase 2 randomized clinical trial of intravitreal bevacizumab for diabetic macular edema  Ophthalmology, 1141860-1867
  34. Diabetic Retinopathy Clinical Research Networ(2007)Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema  Archives of Ophthalmology, 125(4),469-80
  35. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of Ocular Complications of AIDS Research Grou(2007)Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular diagnoses at enrollment  Ophthalmology, 114780-786
  36. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of Ocular Complications of AIDS Research Grou(2007)Longitudinal Study of the Ocular Complications of AIDS. 2. Ocular examination results at enrollment  Ophthalmology, 114787-793
  37. Diabetic Retinopathy Clinical Research Networ(2007)Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema  Ophthalmology, 114(3),525-36
  38. Diabetic Retinopathy Clinical Research Networ(2007)Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema  Ophthalmology, 114(8),1520-5
  39. Geisen P, McColm JR, Hartnett M(2006)Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor.  Experimental Eye Research, 82(4),608-19
  40. McColm JR, Geisen P, Peterson LJ, Hartnett M(2006)Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis.  Experimental Eye Research, 83(2),438-46
  41. Escaravage GK Jr, Cohen KL, Patel SB, Hartnett ME, Armstrong BD, Janowski C(2006)Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus.  Journal of Cataract and Refractive Surgery, 32(5),803-11
  42. Hartnett ME, McColm J(2006)Fibrovascular organization in the vitreous following laser for ROP: implications for prognosis.  Retina, 26(7 Suppl),S24-31
  43. Balasubramanian M, Capone A Jr, Hartnett ME, Pignatto S, Trese M(2006)The Photographic Screening for Retinopathy of Prematurity Study (Photo-ROP): study design and baseline characteristics of enrolled patients.  Retina, 26(7 Suppl),S4-10
  44. Geisen P, McColm JR, King BM, Hartnett M(2006)Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture.  Current Eye Research, 31(9),739-48
  45. Hartnett ME, Martiniuk DJ, Saito Y, Geisen P, Peterson LJ, McColm J(2006)Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.  Investigative Ophthalmology & Visual Science, 47(11),4975-82
  46. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, for the Studies of Ocular Complications of AIDS Research Grou(2006)Causes of Visual Acuity Loss Among Patients with AIDS and Cytomegalovirus in the Era of Highly Active Antiretroviral Therapy  Ophthalmology, 1131441-1445
  47. Diabetic Retinopathy Clinical Research Networ(2006)Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema  Archives of Ophthalmology, 124(12),1701-7
  48. PKC-DRS2 Group (PI for LSU site(2006)Effect of Ruboxistaurin on visual loss in patients with diabetic retinopathy  Ophthalmology, 1132221-2230
  49. Kempen JH, Min Y-I, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA for the Studies of Ocular Complications of AIDS Research Grou(2006)Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis  Ophthalmology, 113684-694
  50. Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo K(2005)Perceived barriers to diabetic eye care: qualitative study of patients and physicians.  Archives of Ophthalmology, 123(3),387-91
  51. Hartnett ME, McColm J(2004)Retinal features predictive of progressive stage 4 retinopathy of prematurity.  Retina, 24(2),237-41
  52. Van Cott EM, Laposata M, Hartnett M(2004)Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis.  Blood Coagulation and Fibrinolysis, 15(5),393-7
  53. McColm JR, Geisen P, Hartnett M(2004)VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.  Molecular Vision, 10512-20
  54. Hartnett ME, Maguluri S, Thompson HW, McColm J(2004)Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity.  Retina, 24(5),753-7
  55. Marshall BC, Jacobson MA, Adler SP in collaboration with the Studies of Ocular Complications of AIDS Research Grou(2004)Avidity of antibodies to cytomegalovirus in HIV-seropositive patients with and without CMV retinitis  Viral Immunology, 17101-108
  56. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK for the Studies of Ocular Complications of AIDS Research Grou(2004)Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment  Ophthalmology, 1112232-2239
  57. Jacobson MA, Maecker HT, Orr PL, D’Amico R, Van Natta M, Li XD Pollard RB, Bredt BM for the Adult AIDS Clinical Trials Groupand the Studies of Ocular Complications of AIDS Research Grou(2004)Results of a CMV-specific CD8+/IFNy+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in AIDS patients with CMV retinitis  Journal of Infectious Diseases, 1891362-1373
  58. Hartnett ME, Laposata M, Van Cott (2003)Antiphospholipid antibody syndrome in a six-year-old female patient.  American Journal of Ophthalmology, 135(4),542-4
  59. Hartnett M(2003)Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity.  Retina, 23(3),322-9
  60. Hartnett ME, Rodier DW, McColm JR, Thompson H(2003)Long-term vision results measured with Teller Acuity Cards and a new Light Perception/Projection Scale after management of late stages of retinopathy of prematurity.  Archives of Ophthalmology, 121(7),991-6
  61. Maguluri S, Hartnett M(2003)Radial choroidal ruptures in sclopetaria.  Journal of the American College of Surgeons, 197(4),689-90
  62. Hartnett ME, Lappas A, Darland D, McColm JR, Lovejoy S, D'Amore P(2003)Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism.  Experimental Eye Research, 77(5),593-9
  63. Kempen JH, Martin BK, Wu A, Barron B, Thorne JE, Jabs DA for the Studies of Ocular Complications of AIDS Research Grou(2003)The effect of cytomegalovirus retinitis on the quality of life of patients with acquired immune deficiency syndrome in the era of highly active anti-retroviral therapy  Ophthalmology, 110987-995
  64. Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D for the Studies of Ocular Complications of AIDS Research Grou(2003)Visual loss in patients with cytomegalovirus retinitis and AIDS before widespread availability of highly active antiretroviral therapy  Archives of Ophthalmology, 121(1),99-107
  65. Miura M, Elsner AE, Beausencourt E, Kunze C, Hartnett ME, Lashkari K, Trempe C(2002)Grading of infrared confocal scanning laser tomography and video displays of digitized color slides in exudative age-related macular degeneration.  Retina, 22(3),300-8
  66. Beausencourt E, Remky A, Elsner AE, Hartnett ME, Trempe C(2000)Infrared scanning laser tomography of macular cysts.  Ophthalmology, 107(2),375-85
  67. Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong (2000)Serum markers of oxidative stress and severity of diabetic retinopathy.  Diabetes Care, 23(2),234-40
  68. The STOP-ROP Multicenter Study Grou(2000)Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A randomized, controlled trial. I: Primary Outcomes  Pediatrics, 105295-310
  69. Sheindlin JA, Hirose T, Hartnett M(1999)Ophthalmic endoscopy: applications in intraocular surgery.  International Ophthalmology Clinics, 39(1),237-47
  70. Andrews AP, Hartnett ME, Hirose (1999)Surgical advances in retinopathy of prematurity.  International Ophthalmology Clinics, 39(1),275-90
  71. Kunze C, Elsner AE, Beausencourt E, Moraes L, Hartnett ME, Trempe C(1999)Spatial extent of pigment epithelial detachments in age-related macular degeneration.  Ophthalmology, 106(9),1830-40
  72. Remky A, Beausencourt E, Hartnett ME, Trempe CL, Arend O, Elsner A(1999)Infrared imaging of cystoid macular edema.  Graefe's Archive for Clinical and Experimental Ophthalmology, 237(11),897-901
  73. Hartnett ME, Garcia CM, D'Amore P(1999)Release of bFGF, an endothelial cell survival factor, by osmotic shock.  Investigative Ophthalmology & Visual Science, 40(12),2945-51
  74. Armstrong D, Ueda T, Ueda T, Aljada A, Browne R, Fukuda S, Spengler R, Chou R, Hartnett M, Buch P, Dandona P, Sasisekharan R, Dorey C(1998)Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor.  Angiogenesis, 2(1),93-104
  75. Hartnett ME, Hirose (1998)Cyanoacrylate glue in the repair of retinal detachment associated with posterior retinal breaks in infants and children.  Retina, 18(2),125-9
  76. Beausencourt E, Elsner AE, Hartnett ME, Trempe C(1997)Quantitative analysis of macular holes with scanning laser tomography.  Ophthalmology, 104(12),2018-29
  77. Armstrong D, Ueda To, Ueda Ta, Browne R, Al-Jada A, Spengler R, Chou R, Fukuda S, Buch P, Dandona P, Hartnett ME, Sasisekharan R, Dorey K(1997)Expression of TNF-alpha and VEGF during retinal neovascularization is initiated by lipid hydroperoxide  Angiogenesis, 2174-84
  78. Hartnett ME, Elsner A(1996)Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging.  Ophthalmology, 103(1),58-71
  79. Steidl SM, Hirose T, Sang D, Hartnett M(1996)Difficulties in excluding the diagnosis of retinoblastoma in cases of advanced Coats' disease: a clinicopathologic report.  Ophthalmologica, 210(6),336-40
  80. Hartnett ME, Weiter JJ, Staurenghi G, Elsner A(1996)Deep retinal vascular anomalous complexes in advanced age-related macular degeneration.  Ophthalmology, 103(12),2042-53
  81. Steidl S, Hirose T, Hartnett M(1995)Open-sky vitrectomy for posterior segment reconstruction in eyes with severe trauma.  International Ophthalmology Clinics, 35(1),175-80
  82. Hartnett ME, Katsumi O, Hirose T, Richardson TM, Walton D(1994)Improved visual function in retinopathy of prematurity after lowering high intraocular pressure.  American Journal of Ophthalmology, 117(1),113-5
  83. Hartnett ME, Pruett RC, DaSilva KC, Burkart P(1994)Antiphospholipid antibody syndrome associated with microscotomata.  American Journal of Ophthalmology, 118(3),397-8
  84. Hartnett ME, Gilbert MM, Hirose T, Richardson TM, Katsumi (1993)Glaucoma as a cause of poor vision in severe retinopathy of prematurity.  Graefe's Archive for Clinical and Experimental Ophthalmology, 231(8),433-8
  85. Hartnett ME, Coles W(1993)Lens clarity after vitrectomy in traumatic lens perforation and vitreous penetration.  American Journal of Ophthalmology, 116(2),250-1
  86. Hartnett ME, Hirose T, Richardson TM, Garsd A, Gilbert MM, Krug J J(1992)Intraocular pressure determination in infants with severe retinopathy of prematurity.  Graefe's Archive for Clinical and Experimental Ophthalmology, 230(5),406-10
  87. Hartnett ME, Weiter JJ, Garsd A, Jalkh A(1992)Classification of retinal pigment epithelial detachments associated with drusen.  Graefe's Archive for Clinical and Experimental Ophthalmology, 230(1),11-9
  88. Hartnett ME, Gilbert MM, Richardson TM, Krug JH Jr, Hirose (1990)Anterior segment evaluation of infants with retinopathy of prematurity.  Ophthalmology, 97(1),122-30
  89. Lazarus HM, Hartnett ME, Reed MD, Murphy BF, Lass J(1987)Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis.  American Journal of Ophthalmology, 104(5),476-80
  90. Mangan KF, Hartnett ME, Matis SA, Winkelstein A, Abo (1984)Natural killer cells suppress human erythroid stem cell proliferation in vitro.  Blood, 63(2),260-9
  91. Krohel GB, Tobin DR, Hartnett ME, Barrows N(1982)Divergence paralysis.  American Journal of Ophthalmology, 94(4),506-10

Edited Book

  1. Hartnett ME, ed-in-chie(2005)Pediatric Retina  ,
  2. Steidl S, Hartnett M(2003)Clinical Pathways in Vitreoretinal Disease  ,
  3. Schepens CL, Hartnett ME, Hirose (2000)Schepens’ Retinal Detachment and Allied Diseases  ,

Clinical Trials

Clinical Trials

Video & News